• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甘露糖-6-磷酸/胰岛素样生长因子 2 受体(M6P/IGF2R)在肿瘤发生中的作用。

Mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) in carcinogenesis.

机构信息

Division of Molecular Medicine, Rudjer Bosković Institute, Zagreb, Croatia.

出版信息

Cancer Lett. 2010 Mar 1;289(1):11-22. doi: 10.1016/j.canlet.2009.06.036. Epub 2009 Jul 30.

DOI:10.1016/j.canlet.2009.06.036
PMID:19646808
Abstract

The cation-independent mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) is a multifunctional receptor. It is involved in a variety of cellular processes which become dysregulated in cancer. Its tumor suppressor role was recognized a long time ago. However, due to its multifunctionality, it is not easy to understand the extent of its relevance to normal cellular physiology. Accordingly, it is even more difficult understanding its role in carcinogenesis. This review presents critical and focused highlights of data relating to M6P/IGF2R, obtained during more than 25 years of cancer research.

摘要

阳离子非依赖型甘露糖-6-磷酸/胰岛素样生长因子 2 受体(M6P/IGF2R)是一种多功能受体。它参与了多种细胞过程,这些过程在癌症中失调。它的肿瘤抑制作用很久以前就被认识到了。然而,由于其多功能性,要了解它与正常细胞生理学的相关性程度并不容易。因此,更难理解它在致癌作用中的作用。这篇综述介绍了在超过 25 年的癌症研究中获得的与 M6P/IGF2R 相关的关键和重点数据。

相似文献

1
Mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) in carcinogenesis.甘露糖-6-磷酸/胰岛素样生长因子 2 受体(M6P/IGF2R)在肿瘤发生中的作用。
Cancer Lett. 2010 Mar 1;289(1):11-22. doi: 10.1016/j.canlet.2009.06.036. Epub 2009 Jul 30.
2
Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers.在人类癌症中携带错义突变的胰岛素样生长因子II/甘露糖6-磷酸受体的配体结合改变。
Cancer Res. 1999 Sep 1;59(17):4314-9.
3
Mannose-6-phosphate/insulin-like growth factor II receptor expression and tumor development.甘露糖-6-磷酸/胰岛素样生长因子II受体表达与肿瘤发展。
Biosci Rep. 2006 Feb;26(1):7-17. doi: 10.1007/s10540-006-9002-3.
4
Kinetics of insulin-like growth factor II (IGF-II) interaction with domain 11 of the human IGF-II/mannose 6-phosphate receptor: function of CD and AB loop solvent-exposed residues.胰岛素样生长因子II(IGF-II)与人IGF-II/甘露糖6-磷酸受体第11结构域相互作用的动力学:CD环和AB环溶剂暴露残基的功能
J Mol Biol. 2006 Jun 2;359(2):403-21. doi: 10.1016/j.jmb.2006.03.046. Epub 2006 Apr 6.
5
Mannose 6-phosphate/insulin-like growth factor II receptor mediates the growth-inhibitory effects of retinoids.甘露糖6-磷酸/胰岛素样生长因子II受体介导类视黄醇的生长抑制作用。
Cell Growth Differ. 1999 Aug;10(8):591-600.
6
Imprinted M6p/Igf2 receptor is mutated in rat liver tumors.印记M6p/Igf2受体在大鼠肝肿瘤中发生突变。
Oncogene. 1998 May 28;16(21):2797-802. doi: 10.1038/sj.onc.1201801.
7
Insulin-like growth factor-2/mannose-6 phosphate receptors.胰岛素样生长因子-2/甘露糖-6-磷酸受体
Vitam Horm. 2009;80:667-97. doi: 10.1016/S0083-6729(08)00624-9.
8
Differential expression of the mannose 6-phosphate/ insulin-like growth factor-II receptor in human breast cancer cell lines of different invasive potential.甘露糖6-磷酸/胰岛素样生长因子-II受体在不同侵袭潜能的人乳腺癌细胞系中的差异表达
Med Sci Monit. 2002 Aug;8(8):BR293-300.
9
Mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) variants in American and Japanese populations.美国和日本人群中的甘露糖6-磷酸/胰岛素样生长因子2受体(M6P/IGF2R)变体。
Hum Mutat. 2001;18(1):25-31. doi: 10.1002/humu.1146.
10
Structural insights into the interaction of insulin-like growth factor 2 with IGF2R domain 11.胰岛素样生长因子2与IGF2R结构域11相互作用的结构见解。
Structure. 2007 Sep;15(9):1065-78. doi: 10.1016/j.str.2007.07.007.

引用本文的文献

1
Bladder Cancer: Role of Circular RNAs in Oncogenesis, Tumor Suppression, and Therapeutic Target Identification.膀胱癌:环状RNA在肿瘤发生、肿瘤抑制及治疗靶点识别中的作用
Cancer Genomics Proteomics. 2025 Sep-Oct;22(5):654-682. doi: 10.21873/cgp.20528.
2
Dextrose prolotherapy at varying concentrations ameliorates tendon injury via IGF-2R: an integrated study of Mendelian randomization and an animal model.不同浓度葡萄糖注射疗法通过胰岛素样生长因子2受体改善肌腱损伤:孟德尔随机化与动物模型的综合研究
J Orthop Surg Res. 2025 Jun 2;20(1):556. doi: 10.1186/s13018-025-05977-9.
3
Hepatocellular carcinoma: signaling pathways and therapeutic advances.
肝细胞癌:信号通路与治疗进展
Signal Transduct Target Ther. 2025 Feb 7;10(1):35. doi: 10.1038/s41392-024-02075-w.
4
Genetic variation perspective reveals potential drug targets for subtypes of endometrial cancer.从遗传变异角度揭示子宫内膜癌亚型的潜在药物靶点。
Sci Rep. 2024 Nov 15;14(1):28180. doi: 10.1038/s41598-024-78689-5.
5
Lysosomal enzyme binding to the cation-independent mannose 6-phosphate receptor is regulated allosterically by insulin-like growth factor 2.溶酶体酶与阳离子非依赖型甘露糖 6-磷酸受体的结合受胰岛素样生长因子 2 的变构调节。
Sci Rep. 2024 Nov 6;14(1):26875. doi: 10.1038/s41598-024-75300-9.
6
Lysosome-targeting chimeras containing an endocytic signaling motif trigger endocytosis and lysosomal degradation of cell-surface proteins.含有内吞信号基序的溶酶体靶向嵌合体可触发细胞表面蛋白的内吞作用和溶酶体降解。
Chem Sci. 2024 Oct 1;15(42):17652-62. doi: 10.1039/d4sc05093b.
7
Insulin-Like Growth Factor Signaling in Alzheimer's Disease: Pathophysiology and Therapeutic Strategies.阿尔茨海默病中的胰岛素样生长因子信号传导:病理生理学与治疗策略
Mol Neurobiol. 2025 Mar;62(3):3195-3225. doi: 10.1007/s12035-024-04457-1. Epub 2024 Sep 6.
8
A "One-Step" Strategy for the Global Characterization of Core-Fucosylated Glycoproteome.一种用于核心岩藻糖基化糖蛋白质组全球表征的“一步法”策略。
JACS Au. 2024 May 1;4(5):2005-2018. doi: 10.1021/jacsau.4c00214. eCollection 2024 May 27.
9
Impairing hydrolase transport machinery prevents human melanoma metastasis.抑制水解酶转运机制可阻止人类黑色素瘤转移。
Commun Biol. 2024 May 15;7(1):574. doi: 10.1038/s42003-024-06261-y.
10
Comparative Molecular Characterization and Pharmacokinetics of IgG1-Fc and Engineered Fc Human Antibody Variants to Insulin-like Growth Factor 2 Receptor (IGF2R).比较胰岛素样生长因子 2 受体(IGF2R)的 IgG1-Fc 和工程化 Fc 人抗体变体的分子特征和药代动力学。
Molecules. 2023 Aug 3;28(15):5839. doi: 10.3390/molecules28155839.